Get started
Author

Katy L. Everett

Observed names: K.L. Everett, Katy Everett, Katy L. Everett
OpenAlex ID: A5086641650
Direct Binding Between Orai1 and AC8 Mediates Dynamic Interplay Between Ca 2+ and cAMP Signaling
2012 · Debbie Willoughby, Katy L. Everett, et al. · Science Signaling · 150
ADCY5 Couples Glucose to Insulin Secretion in Human Islets
2014 · David J. Hodson, Ryan K. Mitchell, et al. · Diabetes · 148
PDF
AKAP79/150 Interacts with AC8 and Regulates Ca2+-dependent cAMP Synthesis in Pancreatic and Neuronal Systems
2010 · Debbie Willoughby, Nanako Masada, et al. · Journal of Biological Chemistry · 80
PDF
Structural Insights into Formation of an Active Signaling Complex between Rac and Phospholipase C Gamma 2
2009 · Tom D. Bunney, Olaniyi Opaleye, et al. · Molecular Cell · 71
PDF
Characterization of Phospholipase Cγ Enzymes with Gain-of-Function Mutations
2009 · Katy L. Everett, Tom D. Bunney, et al. · Journal of Biological Chemistry · 64
CD137/OX40 Bispecific Antibody Induces Potent Antitumor Activity that Is Dependent on Target Coengagement
2020 · Miguel Gaspar, John Pravin, et al. · Cancer Immunology Research · 58
Rac Regulates Its Effector Phospholipase Cγ2 through Interaction with a Split Pleckstrin Homology Domain
2008 · Claudia Walliser, Michael Retlich, et al. · Journal of Biological Chemistry · 58
PDF
A key phosphorylation site in AC8 mediates regulation of Ca2+-dependent cAMP dynamics by an AC8–AKAP79–PKA signalling complex
2012 · Debbie Willoughby, Michelle L. Halls, et al. · Journal of Cell Science · 44
Generation of Fcabs targeting human and murine LAG-3 as building blocks for novel bispecific antibody therapeutics
2018 · Katy L. Everett, Matthew Kraman, et al. · Methods · 31
An Improved Targeted cAMP Sensor to Study the Regulation of Adenylyl Cyclase 8 by Ca2+ Entry through Voltage-Gated Channels
2013 · Katy L. Everett, Dermot M. F. Cooper · PLoS ONE · 29
PDF
Membrane Environment Exerts an Important Influence on Rac-Mediated Activation of Phospholipase Cγ2
2011 · Katy L. Everett, Anja Buehler, et al. · Molecular and Cellular Biology · 26
Structure–activity studies of a novel series of isoxazole-3-carboxamide derivatives as TRPV1 antagonists
2010 · Ronald Palin, Lynn Abernethy, et al. · Bioorganic & Medicinal Chemistry Letters · 25
Discovery of potent, soluble and orally active TRPV1 antagonists. Structure–activity relationships of a series of isoxazoles
2011 · Paul Ratcliffe, Lynn Abernethy, et al. · Bioorganic & Medicinal Chemistry Letters · 21
Identification of potent, soluble, and orally active TRPV1 antagonists
2011 · Paul Ratcliffe, John Maclean, et al. · Bioorganic & Medicinal Chemistry Letters · 19
Muscarinic receptors stimulate AC2 by novel phosphorylation sites, whereas Gβγ subunits exert opposing effects depending on the G-protein source
2012 · Jia X. Shen, Sebastian Wachten, et al. · Biochemical Journal · 17
PDF
Abstract 2719: Dual blockade of PD-L1 and LAG-3 with FS118, a unique bispecific antibody, induces CD8+ T-cell activation and modulates the tumor microenvironment to promote antitumor immune responses
2018 · Matthew Kraman, Natalie Fosh, et al. · Cancer Research · 14
The PLC Pathway
2015 · K.L. Everett, M. Katan · Elsevier eBooks · 4
cAMP measurements with FRET-based sensors in excitable cells
2012 · Katy L. Everett, Dermot M.F. Cooper · Biochemical Society Transactions · 4
Abstract PR06: A LAG-3/PD-L1 bispecific antibody inhibits tumour growth in two syngeneic colon carcinoma models
2017 · Katy Everett, Matthew Kraman, et al. · Cancer Immunology Research · 3
Abstract B091: A LAG-3/PD-L1 bispecific antibody inhibits tumor growth in two syngeneic colon carcinoma models
2016 · Jacqueline Doody, Matthew Kraman, et al. · Cancer Immunology Research · 1
Data from CD137/OX40 Bispecific Antibody Induces Potent Antitumor Activity that Is Dependent on Target Coengagement
2023 · Miguel Gaspar, John Pravin, et al.
Data from CD137/OX40 Bispecific Antibody Induces Potent Antitumor Activity that Is Dependent on Target Coengagement
2023 · Miguel Gaspar, John Pravin, et al.
Supplementary Figures from CD137/OX40 Bispecific Antibody Induces Potent Antitumor Activity that Is Dependent on Target Coengagement
2023 · Miguel Gaspar, John Pravin, et al.
Abstract 5651: A LAG-3/PD-L1 bispecific antibody inhibits tumor growth in two syngeneic colon carcinoma models
2017 · Matthew Kraman, Katarzyna Kmiecik, et al. · Cancer Research
The PLC Pathway
2016 · K.L. Everett, M. Katan · Elsevier eBooks
Works count: 26
Citation count: 867
H-index: 15
I10-index: 16
Year
Topic
Type